Abstract
Neuropeptide Y (NPY) is widely distributed in interneurons of the central nervous system (CNS), including the hippocampus and cerebral cortex, in concentrations exceeding those of any other known neuropeptides1,2. Sequence data comparing different species show that NPY is highly conserved3. This suggests a critical role in regulation of regional neuronal excitability. Kainic acid, a glutamate agonist at kainic acid receptors, causes severe limbic motor seizures culminating in status epilepticus4. We here report that NPY administered into the lateral ventricle is a powerful inhibitor of motor as well as electroencephalographic (EEG) seizures induced by kainic acid. This effect was mediated via receptors with a pharmacological profile similar to the recently cloned rat Y5 receptor5. The present study is the first to demonstrate that NPY possesses anticonvulsant activity. This is consistent with the concept that NPY is an endogenous anticonvulsant and suggests that agonists acting at Y5-like receptors may constitute a novel group of drugs in antiepileptic therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Tatemoto, K., Carlquist, M. & Mutt, V. Neuropeptide Y - a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296, 659–660 (1982).
Chronwall, B.M. et al. The anatomy of neuropeptide-Y-containing neurons in the rat brain. Neuroscience 15, 1159–1181 (1985).
Wahlestedt, C. & Reis, D.J., Neuropeptide Y-related peptides and their receptors -are the receptors potential therapeutic drug targets?. Annu. Rev. Pharmacol. Toxicol. 32, 309–352 (1993).
Sperk, G. Kainic acid seizures in the rat. Prog. Neurobiol. 42, 1–32 (1994).
Gerald, C. et al. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature 382, 168–171 (1996).
Gehlert, D.R. Subtypes of receptors for neuropeptide Y: Implications for the targeting of therapeutics. Life Sci. 55, 551–562 (1994).
Weinberg, D.H. et al. Cloning and expression of a novel neuropeptide Y receptor. J. Biol. Chem. 271, 16435–16438 (1996).
Bard, J.A., Walker, M.W., Branchek, T.A. & Weinshank, R.L. Cloning and functional expression of a human Y4 subtype receptor for pancreatic polypeptide, neuropeptide Y, and peptide YY. J. Biol. Chem. 270, 26762–26765 (1995).
Larhammer, D. et al. Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1-type. J. Biol. Chem. 267, 10935–10938 (1992).
Rose, P.M. et al. Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor. J. Biol. Chem. 270, 22661–22664 (1995).
Greber, S., Schwarzer, C. & Sperk, G. Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro. Br. J. Pharmacol. 113, 737–740 (1994).
McQuiston, A.R., Petrozzino, J.J., Connor, J.A. & Colmers, W.F. Neuropeptide Y1 receptors inhibit N-type calcium currents and reduce transient calcium increases in rat dentate granule cells. J. Neurosci. 16, 1422–1429 (1996).
Colmers, W.F. & Bleakman, D. Effects of neuropeptide Y on the electrical properties of neurons. Trends Neurosci. 17, 373–379 (1994).
Woldbye, D.P.D., Madsen, T.M., Larsen, P.J., Mikkelsen, J.D. & Bolwig, T.G. Neuropeptide Y inhibits hippocampal seizures and wet dog shakes. Brain Res. 737, 162–168 (1996).
Erickson, J.C., Clegg, K.E. & Palmiter, R.D. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381, 415–418 (1996).
Hendry, S.H.C. Organization of neuropeptide Y neurons in the mammalian central nervous system, in The Biology of Neuropeptide Y and Related Peptides. (eds. Colmers, W. F. & Wahlestedt, C.) 65–156 (Humana, Totowa, NJ, 1993).
Szreder, Z., Hori, T. & Kaizuka, Y. Thermoregulatory effect of intracerebral injections of neuropeptide Y in rats at different environmental temperatures. Gen. Pharmacol. 25, 85–91 (1994).
Liu, Z., Gatt, A., Mikati, M. & Holmes, G.L. Effect of temperature on kainic acid-nduced seizures. Brain Res. 631, 51–58 (1993).
Sagar, S.M., Sharp, F.R. & Curran, T. Expression of c-fos protein in brain: Metabolic mapping at the cellular level. Science 240, 1328–1331 (1988).
Dreifuss, F.E. et al. Proposal for classification of epilepsies and epileptic syndromes. Epilepsia 26, 268–278 (1985).
Woldbye, D.P.D., Greisen, M.H., Bolwig, T.G., Larsen, P.J. & Mikkelsen, J.D. Prolonged induction of c-fos in neuropeptide Y and somatostatin-immunoreactive neurons of the rat dentate hilus after electroconvulsive stimulation. Brain Res. 720, 111–119 (1996).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Woldbye, D., Larsen, P., Mikkelsen, J. et al. Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors. Nat Med 3, 761–764 (1997). https://doi.org/10.1038/nm0797-761
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nm0797-761
This article is cited by
-
Combinatorial gene therapy for epilepsy: Gene sequence positioning and AAV serotype influence expression and inhibitory effect on seizures
Gene Therapy (2023)
-
Gene therapy for epilepsy
Metabolic Brain Disease (2010)
-
Differential Regulation of c-Fos and FosB in the Rat Brain After Amygdala Kindling
Cellular and Molecular Neurobiology (2006)
-
Effects of Altered Amygdalar Neuropeptide Y Expression on Anxiety-Related Behaviors
Neuropsychopharmacology (2005)